Ostaguard™
Prevention of infection on orthopedic implants
Pre-clinicalActive
Key Facts
Indication
Prevention of infection on orthopedic implants
Phase
Pre-clinical
Status
Active
Company
About Orthobond
Orthobond is a private, pre-revenue medical device technology company founded in 2015, based in Monmouth Junction, New Jersey. It has developed a platform for creating covalently bound antimicrobial nanosurfaces that kill pathogens through mechanical rupture, avoiding antibiotics or chemical leaching. With recent funding, the company is advancing its lead program, Ostaguard™, toward FDA clearance for orthopedic implants while planning expansion into industrial, automotive, and consumer markets.
View full company profile